• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

New dermal filler launched

San Diego - Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release.

San Diego

- Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release.

Elevess is a safe, effective and less expensive alternative for the treatment of facial wrinkles, particularly nasolabial folds. In a radomized, controlled pivotal study of 208 patients, Elevess was shown to be safe and effective for up to six months, according to the company.

Related Videos
E. James Song is featured in this video series.
E. James Song is featured in this video series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
E. James Song is featured in this video series.
E. James Song is featured in this video series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.